(Q68331546)

English

Effects of sulphasalazine and its metabolites on neutrophil chemotaxis, superoxide production, degranulation and translocation of cytochrome b-245

scientific article published on 01 December 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685923%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Effects of sulphasalazine and its metabolites on neutrophil chemotaxis, superoxide production, degranulation and translocation of cytochrome b-245 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685923%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

based on heuristic

inferred from title

author name string

J. H. Wandall

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685923

29 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1685923

29 October 2022

publication date

1 December 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685923%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.1991.tb00529.x

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1991.tb00529.x/fullpdf

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685923%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685923%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685923%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

609-619

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685923%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Advances in drug therapy for inflammatory bowel disease

1

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Absorption, metabolism, and excretion of salicylazosulfapyridine in man

2

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone

5

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway

6

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa

7

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis

8

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species

9

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

The human neutrophil respiratory burst oxidase

10

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Quantitation of superoxide production in human polymorphonuclear leukocytes from normals and 3 types of chronic granulomatous disease

13

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

The extinction coefficient of cytochrome c

14

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes

15

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

The estimation of serum lysozyme: a comparison of four assay methods

16

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation

17

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

The enzymic reduction and kinetics of oxidation of cytochrome b-245 of neutrophils

18

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

A modified procedure for the determination of loukocyte alkaline phosphatase

20

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis

22

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls

24

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Inhibition of leucocyte motility by drugs used in ulcerative colitis

25

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

The Biology and Pathology of Oxygen Radicals

26

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity

27

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Novel cytochrome b system in phagocytic vacuoles of human granulocytes

28

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation

30

1 reference

10.1111/J.1365-2036.1991.TB00529.X

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00529.X

29 October 2022

Identifiers

10.1111/J.1365-2036.1991.TB00529.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685923%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685923%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68331546&oldid=2036139950"